These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31291219)

  • 21. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
    Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of asenapine in clinical practice for the management of bipolar mania.
    Young AH; Altamura AC; González-Pinto AM; Millet B; Wiedemann K
    J Psychopharmacol; 2013 Apr; 27(4 Suppl):3-13. PubMed ID: 23535350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asenapine for the treatment of bipolar disorder.
    Marazziti D; Mucci F; Falaschi V; Dell'Osso L
    Expert Opin Pharmacother; 2019 Aug; 20(11):1321-1330. PubMed ID: 31132287
    [No Abstract]   [Full Text] [Related]  

  • 24. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
    Citrome L
    Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study.
    Grande I; Hidalgo-Mazzei D; Nieto E; Mur M; Sàez C; Forcada I; Vieta E
    Eur Psychiatry; 2015 Jun; 30(4):528-34. PubMed ID: 25682181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):893-903. PubMed ID: 24793403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asenapine in the treatment of borderline personality disorder: an atypical antipsychotic alternative.
    Martín-Blanco A; Patrizi B; Villalta L; Gasol X; Soler J; Gasol M; Pascual JC
    Int Clin Psychopharmacol; 2014 Mar; 29(2):120-3. PubMed ID: 23962963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
    Findling RL; Landbloom RL; Szegedi A; Koppenhaver J; Braat S; Zhu Q; Mackle M; Chang K; Mathews M
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1032-41. PubMed ID: 26598478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):9-10. PubMed ID: 20216523
    [No Abstract]   [Full Text] [Related]  

  • 31. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACS chemical neuroscience molecule spotlight on Saphris.
    Hopkins CR
    ACS Chem Neurosci; 2010 Apr; 1(4):263-4. PubMed ID: 22778826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials.
    Michalak EE; Guiraud-Diawara A; Sapin C
    Curr Med Res Opin; 2014 Apr; 30(4):711-8. PubMed ID: 24329543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Trends on Antipsychotics: Focus on Asenapine.
    Marazziti D; Piccinni A; Baroni S; Mungai F; Presta S; Mucci F; Dell'Osso L
    Curr Med Chem; 2016; 23(21):2204-16. PubMed ID: 27222264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.
    Aguglia A; Mineo L; Rodolico A; Signorelli MS; Aguglia E
    Int Clin Psychopharmacol; 2018 May; 33(3):121-130. PubMed ID: 29189421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asenapine in clinical practice: preliminary results from a naturalistic observational study.
    Gramaglia C; Rizza MC; Gattoni E; Gambaro E; Di Marco S; Coppola I; Rossi A; Jona A; Imperatori F; Prosperini P; Chieppa N; Binda V; Farruggio S; Grossini E; Zeppegno P
    Riv Psichiatr; 2014; 49(6):241-6. PubMed ID: 25668625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of asenapine treatment in clinical practice: Recommendations from a panel of experts.
    Vieta E; Montes JM; Iborra P; Mozos A; Sáez C; Benabarre A
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(3):163-169. PubMed ID: 29960863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asenapine for elderly bipolar manic patients.
    Baruch Y; Tadger S; Plopski I; Barak Y
    J Affect Disord; 2013 Feb; 145(1):130-2. PubMed ID: 22877962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.